Loading…
Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography
•Simultaneous determination of 9 potentially genotoxic aromatic amine impurities.•Method controls all genotoxic impurities in the entire synthetic route of Crotamiton.•40 ppm specification limit was needed for each impurity.•Method development without mass spectrometer detection or analyte preconcen...
Saved in:
Published in: | Journal of pharmaceutical and biomedical analysis 2022-02, Vol.210, p.114544-114544, Article 114544 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713 |
container_end_page | 114544 |
container_issue | |
container_start_page | 114544 |
container_title | Journal of pharmaceutical and biomedical analysis |
container_volume | 210 |
creator | Kalauz, Andrea Kapui, Imre |
description | •Simultaneous determination of 9 potentially genotoxic aromatic amine impurities.•Method controls all genotoxic impurities in the entire synthetic route of Crotamiton.•40 ppm specification limit was needed for each impurity.•Method development without mass spectrometer detection or analyte preconcentration.•Fully validated and the applicability was tested in several samples.
In the recent years control of potentially genotoxic impurities have an increasing importance in the analysis of active pharmaceutical ingredients. Guidelines of different regulatory bodies specify very low limits for these impurities, in many cases the analytical development is challenging to comply with the requirements. In this paper potential genotoxic impurities of Crotamiton drug substance are investigated, a simple and robust gas chromatographic method is developed for the determination of genotoxic impurities in Crotamiton drug substance. One of the main benefits of this method is that it can quantify all potential genotoxic impurities that can be present in the entire synthesis pathway of Crotamiton drug substance. Crotamiton is synthesized from toluidine derivatives, in which the aromatic amine group represents genotoxic alert. In the method development toluidine isomers (o-, m-, p-toluidine), N-ethyl-toluidine isomers (o-, m-, N-ethyl-p-toluidine) and N-methyl-toluidine isomers (o-, m-, N-methyl-p-toluidine) were separated, and the developed gas chromatographic method is validated in accordance with the relevant guidelines at a specification limit of NMT 40 ppm. |
doi_str_mv | 10.1016/j.jpba.2021.114544 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2615918535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708521006555</els_id><sourcerecordid>2615918535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713</originalsourceid><addsrcrecordid>eNp9kM1q3DAURkVpaKZpX6CLomU3nurKkmxDNyXpHwSySaE7IUvXMxpsy5XkIfP21TBpl10JwfkO3EPIO2BbYKA-HraHpTdbzjhsAYQU4gXZQNvUFVfi10uyYU0NVcNaeU1ep3RgjEnoxCtyXYtOtV3XbMjxDjPGyc8m-zDTMNAlZJyzN-N4ojucQw5P3lI_LWv02WOifqY2hmwmn8vC2OyPSJe9iZOxuGZvzViYXUTni4j2RWMStfsYJpPDLpplf3pDrgYzJnz7_N6Qn1-_PN5-r-4fvv24_Xxf2VqqXHEA5xrJahz6GvngjDCucX2jLPQcrGwFCM5aYXsFg22VVK6vXVf-3LEG6hvy4eJdYvi9Ysp68sniOJoZw5o0VyA7aGUtC8ovaDkupYiDXqKfTDxpYPrcWx_0ubc-99aX3mX0_tm_9hO6f5O_gQvw6QJgufLoMepkSxZb4kS0Wbvg_-f_A_SMlPU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2615918535</pqid></control><display><type>article</type><title>Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography</title><source>ScienceDirect Journals</source><creator>Kalauz, Andrea ; Kapui, Imre</creator><creatorcontrib>Kalauz, Andrea ; Kapui, Imre</creatorcontrib><description>•Simultaneous determination of 9 potentially genotoxic aromatic amine impurities.•Method controls all genotoxic impurities in the entire synthetic route of Crotamiton.•40 ppm specification limit was needed for each impurity.•Method development without mass spectrometer detection or analyte preconcentration.•Fully validated and the applicability was tested in several samples.
In the recent years control of potentially genotoxic impurities have an increasing importance in the analysis of active pharmaceutical ingredients. Guidelines of different regulatory bodies specify very low limits for these impurities, in many cases the analytical development is challenging to comply with the requirements. In this paper potential genotoxic impurities of Crotamiton drug substance are investigated, a simple and robust gas chromatographic method is developed for the determination of genotoxic impurities in Crotamiton drug substance. One of the main benefits of this method is that it can quantify all potential genotoxic impurities that can be present in the entire synthesis pathway of Crotamiton drug substance. Crotamiton is synthesized from toluidine derivatives, in which the aromatic amine group represents genotoxic alert. In the method development toluidine isomers (o-, m-, p-toluidine), N-ethyl-toluidine isomers (o-, m-, N-ethyl-p-toluidine) and N-methyl-toluidine isomers (o-, m-, N-methyl-p-toluidine) were separated, and the developed gas chromatographic method is validated in accordance with the relevant guidelines at a specification limit of NMT 40 ppm.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/j.jpba.2021.114544</identifier><identifier>PMID: 34968997</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Aromatic amines ; Chromatography, Gas ; Chromatography, High Pressure Liquid ; Crotamiton ; DNA Damage ; Drug Contamination ; Gas chromatography ; Genotoxic/mutagenic impurities ; Pharmaceutical Preparations ; Toluidines ; Validation</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 2022-02, Vol.210, p.114544-114544, Article 114544</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713</citedby><cites>FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34968997$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kalauz, Andrea</creatorcontrib><creatorcontrib>Kapui, Imre</creatorcontrib><title>Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>•Simultaneous determination of 9 potentially genotoxic aromatic amine impurities.•Method controls all genotoxic impurities in the entire synthetic route of Crotamiton.•40 ppm specification limit was needed for each impurity.•Method development without mass spectrometer detection or analyte preconcentration.•Fully validated and the applicability was tested in several samples.
In the recent years control of potentially genotoxic impurities have an increasing importance in the analysis of active pharmaceutical ingredients. Guidelines of different regulatory bodies specify very low limits for these impurities, in many cases the analytical development is challenging to comply with the requirements. In this paper potential genotoxic impurities of Crotamiton drug substance are investigated, a simple and robust gas chromatographic method is developed for the determination of genotoxic impurities in Crotamiton drug substance. One of the main benefits of this method is that it can quantify all potential genotoxic impurities that can be present in the entire synthesis pathway of Crotamiton drug substance. Crotamiton is synthesized from toluidine derivatives, in which the aromatic amine group represents genotoxic alert. In the method development toluidine isomers (o-, m-, p-toluidine), N-ethyl-toluidine isomers (o-, m-, N-ethyl-p-toluidine) and N-methyl-toluidine isomers (o-, m-, N-methyl-p-toluidine) were separated, and the developed gas chromatographic method is validated in accordance with the relevant guidelines at a specification limit of NMT 40 ppm.</description><subject>Aromatic amines</subject><subject>Chromatography, Gas</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Crotamiton</subject><subject>DNA Damage</subject><subject>Drug Contamination</subject><subject>Gas chromatography</subject><subject>Genotoxic/mutagenic impurities</subject><subject>Pharmaceutical Preparations</subject><subject>Toluidines</subject><subject>Validation</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kM1q3DAURkVpaKZpX6CLomU3nurKkmxDNyXpHwSySaE7IUvXMxpsy5XkIfP21TBpl10JwfkO3EPIO2BbYKA-HraHpTdbzjhsAYQU4gXZQNvUFVfi10uyYU0NVcNaeU1ep3RgjEnoxCtyXYtOtV3XbMjxDjPGyc8m-zDTMNAlZJyzN-N4ojucQw5P3lI_LWv02WOifqY2hmwmn8vC2OyPSJe9iZOxuGZvzViYXUTni4j2RWMStfsYJpPDLpplf3pDrgYzJnz7_N6Qn1-_PN5-r-4fvv24_Xxf2VqqXHEA5xrJahz6GvngjDCucX2jLPQcrGwFCM5aYXsFg22VVK6vXVf-3LEG6hvy4eJdYvi9Ysp68sniOJoZw5o0VyA7aGUtC8ovaDkupYiDXqKfTDxpYPrcWx_0ubc-99aX3mX0_tm_9hO6f5O_gQvw6QJgufLoMepkSxZb4kS0Wbvg_-f_A_SMlPU</recordid><startdate>20220220</startdate><enddate>20220220</enddate><creator>Kalauz, Andrea</creator><creator>Kapui, Imre</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220220</creationdate><title>Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography</title><author>Kalauz, Andrea ; Kapui, Imre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aromatic amines</topic><topic>Chromatography, Gas</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Crotamiton</topic><topic>DNA Damage</topic><topic>Drug Contamination</topic><topic>Gas chromatography</topic><topic>Genotoxic/mutagenic impurities</topic><topic>Pharmaceutical Preparations</topic><topic>Toluidines</topic><topic>Validation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kalauz, Andrea</creatorcontrib><creatorcontrib>Kapui, Imre</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kalauz, Andrea</au><au>Kapui, Imre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>2022-02-20</date><risdate>2022</risdate><volume>210</volume><spage>114544</spage><epage>114544</epage><pages>114544-114544</pages><artnum>114544</artnum><issn>0731-7085</issn><eissn>1873-264X</eissn><abstract>•Simultaneous determination of 9 potentially genotoxic aromatic amine impurities.•Method controls all genotoxic impurities in the entire synthetic route of Crotamiton.•40 ppm specification limit was needed for each impurity.•Method development without mass spectrometer detection or analyte preconcentration.•Fully validated and the applicability was tested in several samples.
In the recent years control of potentially genotoxic impurities have an increasing importance in the analysis of active pharmaceutical ingredients. Guidelines of different regulatory bodies specify very low limits for these impurities, in many cases the analytical development is challenging to comply with the requirements. In this paper potential genotoxic impurities of Crotamiton drug substance are investigated, a simple and robust gas chromatographic method is developed for the determination of genotoxic impurities in Crotamiton drug substance. One of the main benefits of this method is that it can quantify all potential genotoxic impurities that can be present in the entire synthesis pathway of Crotamiton drug substance. Crotamiton is synthesized from toluidine derivatives, in which the aromatic amine group represents genotoxic alert. In the method development toluidine isomers (o-, m-, p-toluidine), N-ethyl-toluidine isomers (o-, m-, N-ethyl-p-toluidine) and N-methyl-toluidine isomers (o-, m-, N-methyl-p-toluidine) were separated, and the developed gas chromatographic method is validated in accordance with the relevant guidelines at a specification limit of NMT 40 ppm.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>34968997</pmid><doi>10.1016/j.jpba.2021.114544</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0731-7085 |
ispartof | Journal of pharmaceutical and biomedical analysis, 2022-02, Vol.210, p.114544-114544, Article 114544 |
issn | 0731-7085 1873-264X |
language | eng |
recordid | cdi_proquest_miscellaneous_2615918535 |
source | ScienceDirect Journals |
subjects | Aromatic amines Chromatography, Gas Chromatography, High Pressure Liquid Crotamiton DNA Damage Drug Contamination Gas chromatography Genotoxic/mutagenic impurities Pharmaceutical Preparations Toluidines Validation |
title | Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T09%3A25%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20of%20potentially%20genotoxic%20impurities%20in%20crotamiton%20active%20pharmaceutical%20ingredient%20by%20gas%20chromatography&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Kalauz,%20Andrea&rft.date=2022-02-20&rft.volume=210&rft.spage=114544&rft.epage=114544&rft.pages=114544-114544&rft.artnum=114544&rft.issn=0731-7085&rft.eissn=1873-264X&rft_id=info:doi/10.1016/j.jpba.2021.114544&rft_dat=%3Cproquest_cross%3E2615918535%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2615918535&rft_id=info:pmid/34968997&rfr_iscdi=true |